Genentech contributes $500,000 to support ASH's Minority Medical Student Award Program

December 12, 2005

(ATLANTA, December 10, 2005) - Genentech today will donate $500,000 to the American Society of Hematology (ASH) to help fund the Society's Minority Medical Student Award Program (MMSAP). Genentech representatives will formally announce the grant during the Promoting Minorities in Hematology presentation, held during the 47th Annual Meeting of ASH in Atlanta.

The goal of ASH's MMSAP is to motivate minority medical students to enter the field of hematology. The program provides an eight- to twelve-week research experience for students from the United States and Canada in their early medical school years. Participants have the option of applying for an additional hematology research experience in a subsequent year of medical school. Two mentors support each participant - a research mentor, who monitors the participant's work and progress at the institution where the research is being done, and an advisory mentor, an ASH member who has identified himself or herself as a member of a minority group. Up to ten participants are selected for the program each year.

ASH offers a number of award programs designed to attract a greater number of talented students to hematology. The Society has chosen to focus additional recruitment efforts on groups that are underrepresented in hematology through programs such as the MMSAP and the recently announced ASH-AMFDP, a partnership between ASH and the Harold Amos Medical Faculty Development Program (AMFDP) of the Robert Wood Johnson Foundation, which aims to increase the number of underrepresented minority scholars from the field of hematology with academic and research appointments.

The Genentech grant will help support the MMSAP beginning in 2006.

"ASH is extremely grateful for Genentech's generous support of this program," said Dr. James N. George, President of ASH. "The MMSAP, like all of ASH's award programs aimed at young scientists, was created to draw the brightest and most promising researchers into the field of hematology. ASH believes that talented minority medical students should receive extra encouragement to explore careers in hematology. Genentech's donation will make that possible for years to come."
The American Society of Hematology ( is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.

American Society of Hematology

Related Hematology Articles from Brightsurf:

Study finds gender disparities in hematology research success
Hematologists who complete a mentored training program experience greater levels of academic success than those who do not; however, a study published today in Blood Advances suggests a slight discrepancy in success levels between male and female hematologists.

Survey suggests mentorship in medical school is vital to future of hematology
A survey of US hematology-oncology fellows suggests medical school plays an important role in shaping their interest in pursuing careers in hematology, particularly when students are exposed to hematology and oncology as part of core clerkships in internal medicine and pediatrics.

JAK inhibitors associated with aggressive lymphoma
Austrian researchers have discovered that a small number of patients taking targeted drugs known as Janus kinase (JAK) inhibitors to treat myelofibrosis may develop aggressive lymphomas.

For young adults with blood cancer, pediatric centers may improve survival
Adolescents and young adults with acute leukemia have a survival advantage if they receive treatment at a pediatric cancer center versus an adult center, according to a new study.

Global hematology diagnostics market estimated to expand at a robust CAGR over 2021
Hematology includes various IVD technologies such as blood analysis, flow cytometry, immunodiagnostics, molecular diagnostics, hemostasis, histology, and cytology.

Late-breaking hematology abstracts signal new, near-term therapeutic options for patients
In four clinical trials being presented today during the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta, researchers report promising results suggesting patients with blood disorders and several types of cancer will soon have significantly expanded options for treatment.

American Society of Hematology announces top trainee abstracts of 2016 ASH Annual Meeting
The American Society of Hematology (ASH) is pleased to recognize the following trainees with the highest-scoring abstracts in the categories of undergraduate student, medical student, graduate student, resident physician, and postdoctoral fellow at the 58th ASH Annual Meeting Dec.

ASH to expand family of blood journals with launch of new cutting-edge publication
The American Society of Hematology (ASH) will launch an open-access journal to complement Blood, its flagship publication and the most-cited journal in hematology.

Study finds common genetic variants that double risk for blood clots in African Americans
New research published online today in Blood the Journal of the American Society of Hematology, identifies common genetic variants predominantly found in African Americans that double their risk for blood clots.

Mount Sinai researchers present results at American Society of Hematology Meeting
Icahn School of Medicine at Mount Sinai researchers will present several landmark studies at the 2015 American Society of Hematology meeting Dec.

Read More: Hematology News and Hematology Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to